Welcome to our dedicated page for Globe Life SEC filings (Ticker: GL), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
Globe Life Inc. filings document operating results, governance and capital-structure disclosures for an insurance holding company focused on life and supplemental health insurance. Current reports include earnings releases furnished on Form 8-K, with disclosures on net income, net operating income, underwriting margins, premium revenue and guidance.
Proxy and governance filings cover director elections, shareholder voting results, advisory executive compensation matters, board composition, non-employee director compensation and executive retirement plan amendments. The filing record also identifies registered securities including common stock and subordinated debt, alongside recurring disclosures tied to shareholder meetings and corporate governance procedures.
Globe Life Inc. reported solid first quarter 2026 growth, with net income of $3.39 per diluted share, up from $3.01 a year earlier, and net operating income of $3.43 per diluted share, up from $3.07. Total premium revenue rose to $1.27 billion, a 6% increase, driven by 3% growth in life premium and 13% growth in health premium.
Return on equity was strong: net income ROE reached 17.9%, while net operating income ROE excluding AOCI was 14.0%. Book value per share was $77.03, up 19%, and $98.56 excluding AOCI, up 12%. Life net sales increased 6% and health net sales 58%, with notable gains in the United American and Family Heritage divisions.
The company repurchased 1.4 million shares for $203 million at an average price of $141.24 and raised full-year 2026 earnings guidance to a range of $15.40–$15.90 per share, an increase of $0.35 at the midpoint.
GLOBE LIFE INC. EVP & Chief Talent Officer Rebecca E. Zorn exercised stock options and sold shares in a linked set of transactions. She exercised 8,800 Employee Stock Options at an exercise price of $98.32 per share, receiving an equal number of Globe Life common shares.
On the same date, she sold a total of 8,800 common shares in open‑market transactions at prices ranging from about $135.23 to $137.88 per share, including blocks at $135.6593, $136.7147, and $137.4038. After these transactions, she directly held 17,797.0997 Globe Life common shares. Footnotes state detailed price breakdowns are available upon request.
Globe Life Inc receives a Schedule 13G/A amendment from The Vanguard Group reporting that, after an internal realignment, Vanguard and its disaggregated subsidiaries report separate beneficial ownership under SEC Release No. 34-39538. The filing states amount beneficially owned: 0 shares (0%) and lists the redelegation of reporting among Vanguard entities effective 01/12/2026. The amendment is signed by Vanguard's Head of Global Fund Administration on 03/26/2026.
Phillips Sandra L. reported acquisition or exercise transactions in this Form 4 filing.
GLOBE LIFE INC. director Sandra L. Phillips reported receiving a grant or award of 1,174 shares of Common Stock on March 20, 2026 at no purchase price. After this award, she directly holds 1,174 shares of Globe Life common stock, with no indirect shares reported as remaining.
GLOBE LIFE INC. director Derek T. Kan received a grant of 6,433 Director Stock Options on March 18, 2026. These options give him the right to buy 6,433 shares of common stock at an exercise price of $137.62 per share until March 18, 2033.
Following this award, he directly holds 6,433 options and no shares of common stock, either directly or indirectly, according to the reported holdings.
Globe Life Inc. is asking shareholders to vote at its virtual 2026 Annual Meeting on April 30, 2026. The proxy covers four key items: electing 12 directors for one-year terms, an advisory say‑on‑pay vote, approval of the 2026 Incentive Plan, and ratification of Deloitte & Touche as auditor for 2026.
The company highlights strong 2025 results, including net operating income per share from continuing operations of $14.52 and book value per share excluding AOCI of $96.16. Net operating income as return on equity excluding AOCI was 16.0%, while net income as ROE was 20.9%. Governance remains a focus, with 10 of 12 directors deemed independent, fully independent board committees, a lead independent director, and robust risk and sustainability oversight.
Executive pay is positioned as pay‑for‑performance, with equity awards tied to value and dilution and subject to clawbacks, and named executive officer contracts structured without employment agreements. In 2025, shareholders supported the say‑on‑pay proposal with 92% of votes cast, and support has averaged 90% over five years.
GLOBE LIFE INC. Co-Chairman & CEO Frank M. Svoboda reported indirect transfers of common stock as bona fide gifts. On March 11, entities described as a Family Trust and an Irrevocable Trust each gifted 5,000 shares of common stock, for a total of 10,000 shares, with no sale price involved.
After these gifts, Svoboda’s reported holdings include 54,020.4648 common shares held directly, plus additional indirect positions through a Family Trust, a spouse’s irrevocable trust, an irrevocable trust and a 401(k) plan. These are non-market gift dispositions rather than open-market purchases or sales.
Globe Life Inc. Co-Chairman & CEO James Matthew Darden exercised employee stock options for 18,318 shares and received an equal number of common shares at $100.74 each. He then sold 18,318 common shares at an average of $145.1029 and made bona fide gifts totaling 7,358 shares, leaving 51,093.4598 shares held directly plus additional indirect holdings.